EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies

Yen-Jung Kuo, Li-Feng Chen, Yumay Chen, Phang-Lang Chen iD, Hugo Y-H Lin iD

International Journal of Molecular Sciences · 05.05.2026 · 27 (9) · 4120

DOI: 10.3390/ijms27094120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.05.2026. Verfasst von Yen-Jung Kuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: General Division, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. Hauptthemen laut MEDLINE: Mitochondria, Metabolic Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Medical University Chung-Ho Memorial Hospital, Ministry of Science and Technology, Kaohsiung Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American Heart Association (AHA) recently formalized cardiovascular–kidney–metabolic (CKM) syndrome to characterize the systemic interplay among cardiovascular failure, chronic kidney disease (CKD), and metabolic disturbances. Despite evolving clinical management, identifying a unifying cellular driver of this multi-organ deterioration remains a critical priority. This review explores the hypothesis that mitochondrial dysfunction serves as the fundamental pathological nexus of CKM syndrome, driving the progression from early-stage metabolic risk to end-stage organ failure. We synthesize evidence demonstrating how nutrient overload and lipotoxicity precipitate a vicious cycle of bioenergetic failure. In the cardiovascular system, ATP deficiency and impaired mitophagy lead to the structural remodeling observed in both heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). In the kidney, the high mitochondrial density of proximal tubules renders them uniquely susceptible to oxidative stress and mitochondrial DNA (mtDNA) leakage, which subsequently triggers systemic inflammation. Furthermore, we analyze how established therapies—including sodium–glucose co-transporter 2 (SGLT2) inhibitors, Glucagon-like peptide-1 (GLP-1) receptor agonists, and non-steroidal mineralocorticoid receptor antagonists (MRAs)—exert organ-protective effects via mitochondrial mechanisms, promoting metabolic efficiency, reducing reactive oxygen species generation, stabilizing mitochondrial integrity, and promoting mitochondrial quality control processes. Finally, we review emerging mitochondrial-targeted strategies, such as mitoquinol, elamipretide and NAD+ boosters, which aim to restore the SIRT1-PGC-1 α signaling axis. Mitochondria function as the central engines of the CKM axis. A shift toward a mitocentric clinical model may enable earlier intervention and more precise targeting of the mechanisms driving organ crosstalk. Future success depends on multidisciplinary collaboration and the validation of mitochondrial biomarkers to advance precision medicine in CKM syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaMetabolic SyndromeCardiovascular DiseasesHumansAnimalsOxidative Stress

Stichwörter der Autor:innen

CKM syndromecardio-renal-metabolic axismitochondria

Autor:innen und Institutionen

  • General Division, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
  • Department of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807378, Taiwan.
  • Division of Endocrinology, Department of Medicine, School of Medicine, University of California, Irvine, CA 92697, USA.
  • Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA 92697, USA.
  • Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan.

ORCID-Profile: Phang-Lang Chen, Hugo Y-H Lin

Förderung

  • Kaohsiung Medical University Chung-Ho Memorial Hospital
  • Ministry of Science and Technology
  • Kaohsiung Medical University Hospital
  • Kaohsiung Medical University

Zitieren

APA

Kuo, Y. J., Chen, L. F., Chen, Y., Chen, P. L., & Lin, H. Y. (2026). Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies. International Journal of Molecular Sciences, 27(9), 4120. https://doi.org/10.3390/ijms27094120

Vancouver

Kuo YJ, Chen LF, Chen Y, Chen PL, Lin HY. Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies. International Journal of Molecular Sciences. 2026;27(9):4120. doi:10.3390/ijms27094120

BibTeX
@article{Kuo2026,
  author = {Kuo, Yen-Jung and Chen, Li-Feng and Chen, Yumay and Chen, Phang-Lang and Lin, Hugo Y-H},
  title = {Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {4120},
  doi = {10.3390/ijms27094120}
}
Kostenlos starten →